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The type 1 TRH receptor is a GPCR expressed in the anterior pituitary gland. In response to TRH, the receptor activates Gq/11, which in turn stimulates phospholipase C.
The resulting increases in inositol trisphosphate and diacylglycerol cause rapid release of intracellular calcium and activation of protein kinase C. Like many GPCRs, the TRH receptor contains a canonical NPXXY at the end of transmembrane seven in a NPXXY(X) 5-6 F(R/K) motif and is predicted to form an amphipathic 8 th helix with a positively charged face ending at a downstream pair of Cys residues, where palmitoylation occurs .
When TRH binds, the receptor undergoes rapid and quantitative phosphorylation at multiple sites in the cytoplasmic tail . Agonist-stimulated phosphorylation of the receptor drives arrestin binding and arrestin-dependent receptor desensitization and internalization. The receptor tail is not detectably phosphorylated before activation.
Agonist-dependent phosphorylation of GPCRs is usually carried out by either GRKs that recognize the activated state of the receptor or downstream kinases that are activated by receptor signaling. The cytoplasmic tail of the TRH receptor is phosphorylated by GRKs, and GRK2 siRNA and dominant negative GRK2 inhibit phosphorylation in pituitary cells expressing endogenous receptor and transfected HEK293 cells . GRK2 translocates to the plasma membrane in response to TRH addition . Protein kinase C inhibitors and calcium chelators do not interfere with agonist-dependent receptor phosphorylation, suggesting MOL#59733 that diacylglycerol-and calcium-activated kinases are not involved .
There are seven GRKs in mammalian cells, four of which are widely expressed .
GRKs are remarkable in their ability to distinguish between agonist-occupied and inactive receptors, and in their ability to phosphorylate hundreds of GPCRs. These enzymes do not have a rigid sequence requirement for substrates but prefer to phosphorylate at clusters of Ser and Thr surrounded by acidic residues. Most GRK phosphorylation sites are in the cytoplasmic tails or third intracellular loops. GRKs 2 and 3 have C-terminal PH domains and interact directly with Gβγ made available by receptor activation, whereas GRKs 5 and 6 associate with membranes by virtue of lipid modifications and/or hydrophobic helices in their C-terminal segments .
The helix 8 region of GPCRs moves significantly upon receptor activation , making it a candidate for recognition by GRKs. Because the TRH receptor undergoes such rapid and extensive phosphorylation, we tested the hypothesis that helix 8
is required for activation of GRK and report here that the highly conserved positively charged residues play a critical role in receptor phosphorylation.
Materials and Methods
Materials. Embryonic fibroblasts (MEFs) from mice lacking arrestins 2 and 3 were from Dr. Robert Lefkowitz (Duke University, Durham, NC). Plasmids encoding GRKs 3, MOL#59733 1:5000 HRP-conjugated goat anti-mouse antibody, washed three times for 5 min with PBS and analyzed as described above.
In vitro Phosphorylation. Crude membranes were prepared from 10-cm dishes of HEK293 cells expressing either wild type or mutant V5-TRH receptor as follows. Cells were rinsed with ice-cold TM buffer (20 mM Tris, 2 mM MgCl 2 , pH 7.4), scraped into ice cold TM buffer supplemented with 1:1000 protease inhibitors (Calbiochem) and incubated for 20 min. Cells were then homogenized on ice in a Dounce homogenizer and centrifuged at 10,000 x g for 10 min at 4°C. The membrane pellets were resuspended in 50 μl in vitro kinase buffer (20 mM Tris, 2 mM EDTA, 5 mM MgCl 2 , 2 mM ATP, 1 mM GTP, pH 7.5) supplemented with phosphatase inhibitors (10 mM NaF, 10 mM Na 3 PO 4 and 100 nM sodium orthovanadate). GRK2 (100 nM) was added to some samples prior to addition of 100 nM TRH for 5 min at 30°C. Following incubation, 1 ml of ice-cold lysis buffer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, pH 8.0) with phosphatase and protease inhibitors was added. The samples were rotated for 20 min at 4°C and then centrifuged at 10,000 x g for 10 min. The supernatant was incubated with 1:100 affinity-purified Ab6959 overnight at 4°C in lysis buffer, 20 μl of Protein A/G beads (Santa Cruz Biotechnology) were added for 1 h at 4°C and immune complexes were collected by centrifugation. The beads were washed twice with ice-cold lysis buffer and resuspended in LDS sample buffer (Invitrogen) supplemented with DTT.
Electrophoresis and immunoblotting were carried out as described .
GRK2 co-immunoprecipitation. HEK293 cells were co-transfected with DNA encoding V5 epitope-tagged TRH receptors and a kinase-dead mutant of GRK2 (K220R).
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Live cells were incubated at room temperature for 1 hr in HBSS/HEPES with 1:1000
anti-V5 antibody to label surface receptors. Cells were washed and then incubated with TRH for the times noted. Following incubation, cells were lysed on ice with 0.1% ndodecyl-β-D-maltoside in PBS (0.1% NDM buffer) supplemented with protease inhibitors for 20 minutes at 4°C and centrifuged at 10,000 x g for 10 min. Protein A/G beads (20 μl) were added for 1 h at 4°C and immune complexes were collected by centrifugation and washed twice with 0.01% NDM buffer. Electrophoresis and immunoblotting were carried out as described above, using 1:1000 rabbit anti-GRK2
(Santa Cruz Biotechnology) or 1:5000 anti-V5 antibody. 
Results

Receptor Signaling in Helix 8 Mutant Receptors
To examine the importance of positive charges in the helix 8 region of the receptor, we mutated six Arg and Lys residues to glutamines (6Q-TRH receptor). Four of these residues were between the NPXXY motif at the cytoplasmic end of the 7 th transmembrane domain and the palmitoylation sites (Cys335 and Cys337), and two were at residues 338 and 340 (Fig. 1A) . The helix prediction program Jpred3 predicts that wildtype (WT) and all mutant receptors tested have a helical probability of over 80%. Receptors were tagged at the aminoterminus with a V5 epitope.
The relative concentration of different receptor constructs at the cell surface was determined by ELISA; anti-V5 antibody was added to intact cells, such that antibody only had access to extracellular epitopes. We also tested a receptor in which Cys335 and Cys337 were converted to Ser. The TRH receptor is normally palmitoylated at these sites. In agreement with published findings , we found that this mutant signaled strongly, with an EC 50 of 0.9 nM and a maximal response averaging 109% of the WT response (data not shown).
These results indicate that neither positive charge in the helix 8 region nor acylation is required for robust receptor expression and signal transduction.
Importance of Helix 8 Region for Receptor Phosphorylation
We quantified receptor phosphorylation by ELISA using a highly specific phosphosite-specific antibody that has been extensively characterized .
As shown in Fig. 2 , TRH caused more than a 10-fold increase in phosphorylation of the WT-receptor but less than a 50% increase in the 6Q-TRH receptor. Phosphorylation of the WT-receptor was half-maximal at 8 nM TRH ( Fig. 2A) . Phosphorylation of the 6Q-TRH receptor remained low even with long incubation periods and high concentrations of TRH (Fig. 2B ).
Agonist-induced phosphorylation of the WT-TRH receptor occurs at several different sites in the receptor tail . We determined whether positively charged residues in the helix 8 region were important for phosphorylation at different positions using a panel of phosphosite-specific antibodies (Fig. 3) . The 6Q-TRH receptor This article has not been copyedited and formatted. The final version may differ from this version. was poorly phosphorylated at all regions of the cytoplasmic tail, including sites quite distal to helix 8.
To learn whether the helix 8 region has the potential to influence receptor phosphorylation events in other GPCRs, we examined GRK-site phosphorylation of the prototypical class A β2-adrenergic receptor using an antibody directed against two established GRK sites, phospho-Ser 355 and phospho-Ser 356 . We made analogous mutations to those in the 6Q-TRH receptor by converting two Arg residues (328 and 333) between the NPXXY motif and the palmitoylation site (Cys341) and two Arg residues (343 and 344) just after the Cys to Gln. Glutamine substitution of the four Arg residues in the β2-adrenergic receptor did not reduce the isoproterenolstimulated cAMP response (data not shown). As shown in Fig. 4 , the 4Q-mutant β2-adrenergic receptor was phosphorylated only half as much as the wild type receptor in response to all concentrations of isoproterenol. Furthermore this defect, like that of the 6Q-TRH receptor, was not overcome with time, as stimulation with saturating amounts of agonist for as long as 20 minutes did not elicit steady-state phosphorylation greater than half that of wild type receptor.
Identification of Critical Residues
To determine whether a specific segment of helix 8 is required for efficient receptor phosphorylation, we mutated pairs of Lys and Arg residues and measured phosphorylation in response to TRH, again correcting for differences in receptor expression at the plasma membrane (Fig. 5 ). The two Lys residues distal to the palmitoylation site (338, 340) were not involved, because mutating them to Gln had no effect. Mutation of the four positive residues between transmembrane domain 7 and the This article has not been copyedited and formatted. The final version may differ from this version. palmitoylation site (4Q) greatly impaired TRH-dependent phosphorylation. Interestingly, the two Lys residues at positions 332 and 333 appeared to be unimportant, whereas positive charges at residues 326 and 328 were required. In fact, mutation of a single amino acid, Lys326, caused a marked decrease in TRH-dependent receptor phosphorylation. Conversion to Lys326 to Arg did not reduce receptor phosphorylation, ruling out mechanisms depending on ubiquitination and emphasizing the importance of positive charge at this position. A minor fraction of WT TRH receptor is ubiquitinated, apparently as part of a quality control mechanism, but no ubiquitinated receptor is found on the plasma membrane (Cook et al., 2003) .
Mutation of the Cys residues at positions 335 and 337 to Ala inhibited receptor phosphorylation by almost 60%, whereas mutation to Ser completely prevented phosphorylation. The same results were obtained when the Cys-substituted receptors were tested with antibodies against more distal phosphosites (data not shown). Our antibodies would not detect phosphorylation at Ser335 or Ser337, which are potential protein kinase C sites. Phosphorylation at the introduce Ser residues might explain the failure of the C(335,337)S-receptor to undergo phosphorylation at the major sites used in the WT receptor. In fact, inclusion of 10 μM GF109203X, a protein kinase C inhibitor, increased phosphorylation of the C(335,337)S receptor at GRK sites, although not to levels observed with C(335,337)A-or WT-receptors (data not shown). Because the C(335,337)A mutant was significantly phosphorylated, it is clear that palmitoylation is not an absolute requirement for receptor phosphorylation.
Arrestin-dependent Events
This article has not been copyedited and formatted. The final version may differ from this version. . We characterized arrestin-receptor interactions by co-expressing different TRH receptors with arrestin3-GFP (Fig. 6) . Addition of TRH to cells expressing WT-receptor resulted in rapid translocation of arrestin-GFP to the plasma membrane and internalization of the arrestin-GFP-receptor complex into vesicles. In contrast, arrestin3-GFP was not recruited to activated 6Q-TRH receptors, nor did it move into vesicles during the next 30 min.
We also determined the ability of the 6Q-and other mutant TRH receptors to form an acid-stable complex with agonist ( Fig. 7A ) and to undergo internalization, based on the amount of N-terminal V5 receptor epitope accessible to antibodies in intact cells before and after addition of TRH (Fig. 7B) . The 6Q-TRH receptor formed a less acidresistant complex with agonist and internalized less extensively than the WT-receptor.
The acid-resistance of K326 and C335,337 mutants paralleled their ability to undergo phosphorylation, while internalization of the K326Q mutant was surprisingly high. The results are reminiscent of previous studies showing that the TRH receptor retains some ability to form an acid-resistant complex and undergo endocytosis in arrestin-null cells , pointing to the existence of an uncharacterized arrestinindependent pathway.
The arrestin-TRH receptor complex has much higher affinity for TRH than the nonphosphorylated receptor , just as other GPCR-arrestin complexes bind agonists with higher affinity than the GPCRs alone This article has not been copyedited and formatted. The final version may differ from this version. 
Analysis of Phosphorylation Defect
As discussed above, GRK2 has been implicated in phosphorylation of the TRH receptor cytoplasmic tail. We overexpressed GRK2 to determine whether this would overcome the deficit in phosphorylation observed with the 6Q-TRH receptor. GRK2
increased phosphorylation of 6Q-and WT-TRH receptors, but overexpression of the kinase did not fully restore phosphorylation of the mutant receptor (Fig. 8 ). GRK3 caused a small increase in basal receptor phosphorylation of the 6Q receptor and, like GRK2, increased phosphorylation in response to TRH. Overexpression of GRKs 5 and 6, which are membrane localized all the time , increased basal phosphorylation of WT-and 6Q-substituted receptors.
Interactions of the WT-and 6Q-receptors with GRK2 were characterized in cells transfected with receptor and kinase-dead K220R-GRK2. Surface receptors were labeled with anti-V5 antibodies and cells were exposed to TRH for various times. Receptors were solubilized in n-dodecyl-β-D-maltoside and immunoblots were probed for total receptor This article has not been copyedited and formatted. The final version may differ from this version. and GRK2 (Fig. 9A) . TRH rapidly increased the amount of kinase associated with the WT-receptor but exerted a much smaller effect on the 6Q-receptor, which showed stronger association with the kinase in the absence of agonist. On average, TRH increased GRK2 co-precipitated with receptor 6.9-fold for WT and 1.5-fold for 6Q-receptors at 2 min, when responses peaked. TRH caused a strong shift in the mobility of the WT-receptor but only a small change in mobility of the 6Q-receptor, consistent with differences in phosphorylation.
Similar results were obtained when recruitment of endogenous GRK2 to the membrane was monitored. Most endogenous GRK2 was already membrane-associated in nontransfected cells. The ratio of membrane:soluble GRK2 reached a maximum 30 sec after TRH addition, increasing 2. 8± 1.1-fold in cells expressing WT-receptor and 1.5 ± 0.7-fold (n=3) in cells expressing the 6Q-substituted receptor, but these differences were not statistically significant (data not shown). Both approaches suggest that GRK2
associates less strongly with activated receptor when charged residues in helix 8 are replaced. This deficit could result from either failure of the 6Q receptor to recruit the kinase or weaker association because the receptor does not bind well to the enzyme active site.
To test whether the 6Q-TRH receptor could serve as a substrate for GRK2 under conditions where kinase recruitment was not an issue, we carried out in vitro phosphorylation assays using membranes from cells expressing 6Q-, K326Q and WT-TRH receptors and purified GRK2. The extent of phosphorylation was analyzed by solubilizing receptors and then immunoprecipitating with phosphosite-specific antibody 6959, which recognizes TRH receptors phosphorylated at residues between 355 and 365.
This article has not been copyedited and formatted. The final version may differ from this version. The experiment was designed in this manner because phosphosite-specific antibodies against the TRH receptor work well for immunoprecipitation but not for immunoblotting.
To verify that antibody 6959 can immunoprecipitate phosphorylated 6Q-TRH receptors, we overexpressed GRK6 and treated cells expressing either WT-or 6Q-receptors with TRH to drive phosphorylation. Antibody 6959 efficiently immunoprecipitated WT-and 6Q-TRH receptors under these conditions (Fig. 9B) .
The WT-receptor was partially phosphorylated by endogenous kinases when membranes were incubated with TRH in ATP-containing buffer and more extensively phosphorylated when purified GRK2 was added (Fig. 9C) . Phosphorylation of the WTreceptor was completely dependent on agonist stimulation. In contrast, the 6Q-TRH receptor was not phosphorylated alone or in the presence of GRK2 and the K326Q receptor was only slightly phosphorylated. Receptors were expressed at comparable concentrations in these experiments.Results from the in vitro phosphorylation assays establish that GRK2 is not active towards receptors lacking critical Lys and Arg residues in helix 8.
Activation of a single rhodopsin molecules leads to phosphorylation of hundreds of others, a phenomenon referred to as high-gain or trans-phosphorylation (reviewed in (Hurley et al., 1998) ). Trans-phosphorylation occurs with the TRH receptor too, because a non-activatable mutant TRH receptor that binds agonist but does not become phosphoryated can undergo phosphorylation if it is co-expressed with an activatable receptor lacking phosphorylation sites . Here we tested whether the 6Q-TRH receptor, which possesses all Ser and Thr residues in the receptor tail, becomes phosphorylated when expressed with a mutant TRH receptor (11Ala) lacking all 11
This article has not been copyedited and formatted. The final version may differ from this version. conserved Ser and Thr residues in the C-terminal domain, including the four residues recognized by the phosphosite-specific antibody. If the 11Ala mutant can activate GRK when paired with the 6Q receptor, then phosphorylation of the 6Q-receptor might occur, as it is the only substrate. As shown in Fig. 10 , co-expression of 11Ala-with 6Q-TRH receptors resulted in a significant increase in TRH-stimulated phosphorylation of the 6Q
receptor, to about 20% of the level observed with WT receptor. It is noteworthy that only a fraction of 6Q-receptors would be expected to participate in the formation of 6Q-11Ala, as opposed to 6Q-6Q, dimers.
Discussion
The helix 8 region of GPCRs forms an amphipathic helix that lies parallel to the plasma membrane and is anchored by palmitoylated Cys groups . Helix 8 is believed to move upon receptor activation. For example, disulfide crosslinking approaches show that the aminoterminal part of helix 8 of the M3 muscarinic receptor lies close to the cytoplasmic end of transmembrane helix 1 when the receptor is in an inactive state but moves away when the receptor binds agonist . Spin labeling studies of rhodopsin indicate movement in the helix 8 region following rhodopsin activation . Crystallographic studies of opsin bound to a peptide from Gα, which is proposed to resemble the activated state of rhodopsin, suggest that a kink between the end of the 7 th transmembrane domain and helix 8 is rearranged when the receptor assumes an activated conformation . We have shown here that mutation of positively charged residues in helix 8 produces a TRH receptor that signals strongly in response to agonist, implying that it is essentially normal in its interactions with G protein, but is not phosphorylated by GRKs.
This article has not been copyedited and formatted. The final version may differ from this version. type-2 receptor also results in an intracellularly trapped receptor, but no trafficking defect is observed when only the polar residues are mutated . In a few cases, alterations in helix 8 cause constitutive activity and in one, constitutive phosphorylation ).
Several investigators have surveyed GPCR sequences and noted that a Phe-Lys/Arg motif is often found five or six residues downstream from the Tyr of the canonical NPXXY at the end of the 7 th transmembrane domain. The NPXXY at the cytoplasmic end of transmembrane helix 7 forms ionic and hydrogen bonds with the downstream Phe and in some GPCRs, intracellular loop 1 . The helix 8 region of the type1 TRH receptor adheres to this pattern and is highly conserved. Furthermore, the type 1 and type 2 mouse Several studies suggest direct contact between helix 8 of GPCRs and G proteins.
Peptides from helix 8 of rhodopsin bind directly to transducin and Gβγ and the helix 8 segments of the β1-adrenergic and angiotensin II receptors interact with G protein subunits .
Cell-permeant peptides from the helix 8 region of PAR1 disrupt G protein-coupling , and many GPCRs cannot signal effectively after truncation or mutation of helix 8 ). The discrepancy between the effect of mutations in helix 8 on G protein-dependent signaling and GRK-mediated phosphorylation of the TRH receptor was not predicted, although a similar dissociation has been reported for rhodopsin, where certain mutations in the first intracellular loop block phosphorylation without preventing transducin binding . Recently, Zidar et al. reported that one peptide agonist for the CCR7 receptor activates phosphorylation by GRK6 and GRK3, while another activates phosphorylation by GRK6 only; both peptides stimulate G protein signaling ). Thus, receptor conformations necessary for activation of G proteins can be distinguished from those required for activation of GRKs by receptor mutation, as shown here, and with selective ligands, as shown for CCR7
receptors.
The WT-TRH receptor is a superb substrate for GRKs, undergoing nearly quantitative GRK-mediated phosphorylation in seconds in response to agonist. The loss of positive charge in helix 8 converts the receptor to a very poor substrate, even though the most important charged residue in helix 8, Lys326, is some distance upstream from This article has not been copyedited and formatted. The final version may differ from this version. the major phosphorylation site at Thr365 . GRK2, which is primarily responsible for TRH receptor phosphorylation , is recruited to the plasma membrane in part by Gβγ released upon receptor activation. The defect in 6Q-TRH receptor phosphorylation is unlikely to result from inadequate recruitment of GRK2
by Gβγ, because the mutant receptor activates Gβγ effectively and phosphorylation is not restored by overexpression of GRK2 in cells or addition of purified GRK2 to isolated membranes.
GRKs are thought to make multiple contacts with activated GPCRs. Peptides derived from intracellular loops 2 and 3 and the proximal tail of rhodopsin interact with rhodopsin kinase (GRK1) .
Peptides from several domains of the β2-adrenergic receptor inhibit the activity of purified GRK2, with the strongest interaction between intracellular loop 1 and the kinase . Three different regions of the β2-adrenergic receptor tail show little apparent affinity for GRK2, but the proximal end of helix 8 has not been tested . The structures of GRK2 alone and in complexes with Gβγ and Gα q have been solved SterneMarr et al., 2009; , and GRK2 appears to be capable of interacting simultaneously with Gβγ, Gα q and receptor. Molecular modeling suggests that one molecule of GRK2 may interact with a GPCR dimer . Tesmer and coworkers identified a surface in the aminoterminal region and kinase domains of GRKs 1 and 2 that is critical for kinase interaction with activated GPCRs. The cytoplasmic tail of the receptor sits in an open groove on the kinase while different regions of the receptor interact elsewhere with the enzyme. The idea of multiple contact points is supported by observations showing that the activity of GRKs towards peptide substrates is increased dramatically in the presence of receptor .
Our data suggest that positively charged residues in the helix 8 region are involved in GRK activation. Conversion of these residues to Gln may disrupt the helical nature of helix 8, or may disrupt association with negatively charged membrane lipids, thereby altering kinase recognition of the receptor. It is uncertain whether these amino acids contact the kinase directly or are necessary for the agonist-occupied receptor to achieve a conformation capable of activating the enzyme. In the present study, co-expression of the 11Ala-TRH receptor, which has an intact helix 8 but no phosphorylation sites, potentiated the normally weak phosphorylation of 6Q-TRH receptors. This finding suggests that the 11Ala-receptor may make the necessary contacts with GRK to cause the kinase domain to close and allow phosphorylation of the 6Q-receptor in a dimer pair. Consistent with this, a mutant TRH receptor that cannot be activated or phosphorylated on its own undergoes GRK-dependent phosphorylation when it is expressed with a mutant receptor that signals strongly but lacks phosphorylation sites . This article has not been copyedited and formatted. The final version may differ from this version. Backgrounds were identical in mock-transfected cells and cells not exposed to TRH.
Results show mean and range of duplicates in a representative experiment. Results of two independent experiments performed in duplicate are shown. A. Cells expressing WT-or 6Q-TRH receptors with or without K220R-GRK2 were incubated with antibody to V5 to label surface receptors, washed, and incubated with or without 10 μM TRH for 0 to 5 min. Receptors were solubilized with dodecyl-β-Dmaltoside and immune complexes were collected on protein A/G beads.
Immunoprecipitates were resolved on SDS-PAGE and blotted for either total receptor This article has not been copyedited and formatted. The final version may differ from this version. (top) or GRK2 (bottom). B. Cells were transfected with WT-or 6Q-receptors with or without GRK6 and exposed to vehicle or 100 nM TRH for 5 min. Proteins were solubilized with Triton X100 and phosphorylated and total receptors were immunoprecipitated with antibodies to phosphoreceptor (Ab6959) (top) and V5 epitope (bottom), respectively, resolved on gels and blotted with anti-V5 antibody. C.
Membranes were isolated from cells expressing WT-, 6Q-or K326Q-TRH receptors and incubated in in vitro kinase buffer with or without 100 nM TRH and 100 nM GRK2 for 5 min. Immunoprecipitation and immunoblotting were carried out as in B. Densitometric analysis of blots of total receptor in lysates from the same experiment (not shown)
revealed that 6Q-and K326Q-receptors were expressed at 92 and 65% of WT, respectively. Arrestin2/3KO MEF Mock 20.1 ± 2.6 13.8 ± 3.6 +Arrestin3 1.4 ± 0.2 11.9 ± 1.5
